SCHEMBL30601823

SCHEMBL30601823

O=C(N[C@H]1CCNC[C@@H]1F)C1(Cc2cccc(F)c2)CC1

nearest known ligand 0.79

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ SSTR4 P31391 5/20 0.79
▸ SSTR1 P30872 4/20 0.73
▸ CHRM1 P11229 12/20 0.46
▸ FPR2 P25090 1/20 0.41
▸ PRKAA2 P54646 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26121549 1.00 SSTR4 (0.79) SSTR4SSTR1CHRM1FPR2PRKAA2
SCHEMBL30601834 0.88 SSTR4 (0.78) SSTR4SSTR1CHRM1
SCHEMBL26123784 0.88 SSTR4 (0.78) SSTR4SSTR1CHRM1
SCHEMBL26124855 0.88 SSTR4 (1.00) SSTR4SSTR1CHRM1
SCHEMBL26126614 0.88 SSTR4 (0.73) SSTR4SSTR1CHRM1FPR2PRKAA2
SCHEMBL26125710 0.88 SSTR4 (0.77) SSTR4SSTR1CHRM1FPR2PRKAA2
SCHEMBL26123975 0.86 SSTR4 (0.77) SSTR4SSTR1CHRM1
SCHEMBL26124881 0.84 SSTR4 (1.00) SSTR4SSTR1CHRM1FPR2
SCHEMBL26124582 0.82 SSTR4 (0.72) SSTR4SSTR1CHRM1FPR2PRKAA2
SCHEMBL30601808 0.82 SSTR4 (0.65) SSTR4SSTR1CHRM1FPR2PRKAA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119585238-A N- (pyrrolidin-3-yl or piperidin-4-yl) acetamide derivatives 武田药品工业株式会社 2025-03-07 — — CN claimed
CN-119585238-A N- (pyrrolidin-3-yl or piperidin-4-yl) acetamide derivatives 武田药品工业株式会社 2025-03-07 — — CN disclosed
EP-4499224-A1 N-(PYRROLIDIN-3-YL OR PIPERIDIN-4-YL)ACETAMIDE DERIVATIVES Takeda Pharmaceutical Company Limited (JP) 2025-02-05 — — EP disclosed
WO-2023187677-A1 N-(PYRROLIDIN-3-YL OR PIPERIDIN-4-YL)ACETAMIDE DERIVATIVES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2023-10-05 — — WO disclosed
Send feedback